Novel Laboratories, Inc. D.B.A LUPIN FDA Record
- Last warning letter 2021
Novel Laboratories, Inc. D.B.A LUPIN has 1 FDA recall, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. FDA has issued 1 warning letter to Novel Laboratories, Inc. D.B.A LUPIN, the most recent on Jun 11, 2021. FDA has published 1 Form 483 for Novel Laboratories, Inc. D.B.A LUPIN.
- Latest recall
- D-0726-2021 · Class II · Jul 29, 2021
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing Novel Laboratories, Inc. D.B.A LUPIN as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Novel Laboratories, Inc. D.B.A LUPIN yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Novel Laboratories, Inc. D.B.A LUPIN FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jun 11, 2021 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated | Office of Pharmaceutical Quality Operations Division I | Apr 19, 2023 |
Novel Laboratories, Inc. D.B.A LUPIN Form 483s
| Date | Document | FEI |
|---|---|---|
| Nov 5, 2020 · Document on fda.gov | 483 | 3006271438 |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0726-2021 | Class II | GaviLyteTM - C PEG-3350 (240g) and Electrolytes for Oral Solution, USP with Flavor Pack Manufactured… | Jul 29, 2021 |
Novel Laboratories, Inc. D.B.A LUPIN and the FDA: common questions
Has Novel Laboratories, Inc. D.B.A LUPIN received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Novel Laboratories, Inc. D.B.A LUPIN. The most recent is dated Jun 11, 2021, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".
Has Novel Laboratories, Inc. D.B.A LUPIN received an FDA Form 483?
FDA has published 1 Form 483 for Novel Laboratories, Inc. D.B.A LUPIN in its reading room, the most recent dated Nov 5, 2020. FDA publishes some Form 483s, not all of them.
Has Novel Laboratories, Inc. D.B.A LUPIN had an FDA recall?
Yes. Novel Laboratories, Inc. D.B.A LUPIN has 1 FDA recall on record. The most recent started Jul 29, 2021.
Need more than this page shows? Ask about Novel Laboratories, Inc. D.B.A LUPIN in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.